Ayala Pharmaceuticals Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the fourth quarter 2023 to a ratio of 13, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the fourth quarter 2023. Average receivable collection period, for the Ayala Pharmaceuticals Inc in Dec 31 2023 quarter, has decreased to 28 days, compared to 184 days, in the Sep 30 2023 quarter.

If we take a look into Healthcare sector Ayala Pharmaceuticals Inc achieved the highest receivable turnover ratio. While receivables turnover ratio remained unchanged relative to the previous period at no. .

What is Receivable Turnover Ratio?
What is Ayala Pharmaceuticals Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ADXS Receivables Turnover Ratio	(Dec 31 2023) IV. Quarter	(Sep 30 2023) III. Quarter	(Jun 30 2023) II. Quarter	(Mar 31 2023) I. Quarter	(Dec 31 2022) IV. Quarter
Y / Y Receivable Change	-	-	-	-	-
Y / Y Revenue Change	-	-	-	-98.4 %	-
Receivable Turnover Ratio (TTM)	13	1.98	1.98	1.83	6.07
ADXS's Total Ranking	#	#	#	#	#
Accounts Receivable average collection period days	28	184	184	199	60
Seq. Receivable Change	-	-	-	-98.29 %	-
Seq. Revenue Change	-	-	125 %	-96.19 %	-

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	#
Healthcare Sector	#
Overall Market	#

Receivable Turnover Ratio Statistics
High	Average	Low
0	0	0

ADXS Company Profile • Back to ADXS Efficiency Comparisons • Compare ADXS Receivables Turnover Ratio to its Competitors

Financial Statements
Ayala Pharmaceuticals Inc 's Accounts Receivable	$ 0 Millions	Visit ADXS's Balance sheet
Ayala Pharmaceuticals Inc 's Sales TTM	$ 0 Millions	Visit ADXS's Income Statement
Sources of ADXS's Revenues		Visit ADXS's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ADXS's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ADXS's Growth Rates	ADXS's Roa	ADXS's Inventory Turnover Ratio	ADXS's Dividend Comparisons
ADXS's Profitability Ratios	ADXS's Roi	ADXS's Asset Turnover Ratio	ADXS's Dividend Growth
ADXS's Valuation Ratios	ADXS's Roe	ADXS's Financial Strength Ratios	ADXS's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2023, within Healthcare Sector

Receivable Turnover Ratio

Revenues for 12 Months ending Dec 31 2023

Receivable at quarter ending Dec 31 2023

Date modified: 2026-09-08T15:11:19+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.